Adaptive Interventions for Optimizing Malaria Control: a Cluster-Randomized SMART Trial
NCT04182126 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 122872
Last updated 2024-10-15
Summary
In the past decade, massive scale-up of long-lasting insecticidal nets (LLINs) and indoor residual spraying (IRS) have led to significant reductions in malaria mortality and morbidity. Nonetheless, malaria burden remains high, and a dozen countries in Africa show a trend of increasing malaria incidence over the past several years. The high malaria burden in many areas of Africa underscores the need to improve the effectiveness of intervention tools by optimizing first-line intervention tools and integrating newly approved products into control programs. Vector control is an important component of the national malaria control strategy in Africa. Because transmission settings and vector ecology vary among countries or among districts within a country, interventions that work in one setting may not work well in all settings. Malaria interventions should be adapted and re-adapted over time in response to evolving malaria risks and changing vector ecology and behavior. The central objective of this application is to design optimal adaptive combinations of vector control interventions to maximize reductions in malaria burden based on local malaria transmission risks, changing vector ecology, and available mix of interventions approved by the Ministry of Health in each target country. The central hypothesis is that an adaptive approach based on local malaria risk and changing vector ecology will lead to significant reductions in malaria incidence and transmission risk. The aim of this study is to use a cluster-randomized sequential, multiple assignment randomized trial (SMART) design to compare various vector control methods implemented by the Ministry of Health of Kenya in reducing malaria incidence and infection, and develop an optimal intervention strategy tailored toward to local epidemiological and vector conditions.
Conditions
- LLIN, PBO LLIN, IRS, Larviciding
Interventions
- OTHER
-
Regular long-lasting insecticidal nets
Olyset nets: containing 2% permethrin or PermaNet 2.0 containing 1.8 and 1.4 g/kg, respectively, for 75 and 100 denier yarn
- OTHER
-
LLIN plus Piperonyl butoxide-treated LLIN
Olyset Plus: containing 2% permethrin and 1% PBO
- OTHER
-
Long-lasting microbial larvicide
Semi-permanent and permanent habitats will be treated with FourStar® 180-day Briquets using the recommended dosage of 100 ft2 water surface per briquet
- OTHER
-
Indoor residual spraying with micro-encapsulated pirimiphos-methyl or other insecticides
Each dwelling's interior walls and ceilings will be sprayed with micro-encapsulated pirimiphos-methyl at the recommended dosage of 1g/m² and at the recommended frequency of once a year or twice a year. Other insecticides may be used to replace the Actellic 300 CS depends on Kenya government policy, current policy requires rotating different insecticides annually.
Sponsors & Collaborators
-
University of California, Irvine
lead OTHER
Principal Investigators
-
Guiyun Yan, Ph.D. · University of California at Irvine
-
John Githure, Ph.D. · Tom-Mboya University, Kenya
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- TRIPLE
- Model
- SEQUENTIAL
Eligibility
- Min Age
- 6 Months
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2019-12-01
- Primary Completion
- 2024-08-31
- Completion
- 2024-08-31
Countries
- United States
- Kenya
Study Locations
More Related Trials
-
Efficacy and Safety of High-dose Ivermectin for Reducing Malaria Transmission: A Dose Finding Study
NCT02511353 ·Status: COMPLETED ·Phase: PHASE2
-
Mass Drug Administration of Ivermectin and Dihydroartemisinin-piperaquine as an Additional Intervention for Malaria Elimination
NCT03576313 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy of Amodiaquine-artesunate in Children Aged 6-59 Months With Uncomplicated P. Falciparum Malaria
NCT00425763 ·Status: COMPLETED ·Phase: PHASE4
-
Impact of Insecticide Resistance on Vector Control
NCT01713517 ·Status: UNKNOWN ·Phase: PHASE4
-
Evaluation of Targeted Mass Drug Administration for Malaria in Ethiopia
NCT04241705 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of Oral Activated Charcoal on Antimalarial Drug's Ability to Kill Parasites in Malian Children With Malaria
NCT01955382 ·Status: COMPLETED ·Phase: PHASE2
-
Repeat Ivermectin Mass Drug Administrations for Control of Malaria: a Pilot Safety and Efficacy Study
NCT02509481 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Efficacy of Sulphadoxine-pyrimethamine and Artemisinin-containing Combination Therapy for Malaria
NCT00140361 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of Reactive Focal Mass Drug Administration (rfMDA) +/- Reactive Focal Vector Control (RAVC) in Namibia
NCT02610400 ·Status: COMPLETED ·Phase: PHASE3
-
Integrating Malaria Vaccine With Seasonal Malaria Chemoprevention in West Africa
NCT06860178 ·Status: RECRUITING ·Phase: PHASE4
-
Assessing the Efficacy of Four Drug Combinations as the Next First-line Therapy for Uncomplicated Malaria in Malawi
NCT00164710 ·Status: COMPLETED ·Phase: PHASE4
-
Assessing the Efficacy of Artemisinin Combination Therapies for Treatment of Uncomplicated Malaria Infection in Children
NCT01082705 ·Status: COMPLETED ·Phase: PHASE3
-
Reducing Malaria Transmission in Forest-going Mobile and Migrant Populations in Myanmar
NCT05025761 ·Status: UNKNOWN ·Phase: NA
-
Boosting the Impact of SMC Through Simultaneous Screening and Treatment of Roommates
NCT04816461 ·Status: COMPLETED ·Phase: PHASE4
-
Mass-Drug Administration to Reduce Malaria Transmission
NCT00509015 ·Status: COMPLETED ·Phase: NA
-
Seasonal R21 Mass Vaccination for Malaria Elimination
NCT06578572 ·Status: RECRUITING ·Phase: PHASE3
-
PDMC Implementation Trial in Kenya
NCT06624631 ·Status: RECRUITING ·Phase: PHASE4
-
Reducing Malaria Transmission in Forest-going Mobile and Migrant Populations in Lao PDR and Cambodia
NCT05117567 ·Status: UNKNOWN ·Phase: NA
-
Longitudinal Antimalarial Combinations in Uganda
NCT00123552 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Effectiveness of Combined Therapy for Uncomplicated Malaria Treatment in Peru
NCT00164216 ·Status: COMPLETED
-
Malaria Diagnostic Testing and Conditional Subsidies to Target ACTs in the Retail Sector: TESTsmART Aim 2 - Kenya
NCT04428307 ·Status: COMPLETED ·Phase: NA
-
In Vivo Efficacy of Artemether-Lumefantrine, Amodiaquine-Artesunate, Dihydroartemisinin-Piperaquine, and Pironaridine-Artesunate in Mozambique
NCT05343312 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Efficacy Study of IV Artesunate to Treat Malaria
NCT00298610 ·Status: COMPLETED ·Phase: PHASE2
-
Trial of Artemether-Lumefantrine Alone and in Combination With Ivermectin to Reduce Post-Treatment Malaria Transmission
NCT01603251 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Ivermectin-artemisinin Combination Therapy for Eradication of Malaria
NCT05605925 ·Status: UNKNOWN ·Phase: PHASE4